Drug intelligence / Profile preview

fosinopril + hydrochlorothiazide

Development stage
Phase 1
Lead developer
Bristol Myers Squibb
Modality
Small Molecules
Administration
Oral
01

Overview

Fosinopril + hydrochlorothiazide is an oral fixed-dose antihypertensive combination containing fosinopril, an angiotensin-converting enzyme inhibitor prodrug, and hydrochlorothiazide, a thiazide diuretic. Fosinopril is converted to fosinoprilat, which inhibits angiotensin-converting enzyme and reduces formation of angiotensin II and aldosterone. Hydrochlorothiazide inhibits sodium and chloride reabsorption in the distal convoluted tubule, increasing natriuresis and reducing plasma volume. The combination is used for treatment of hypertension and is not intended as initial therapy.

Brand names
Monopril HCT
Other names
fosinopril hydrochlorothiazidefosinopril sodium + hydrochlorothiazidefosinopril sodium/hydrochlorothiazidefosinopril/hydrochlorothiazide
02

Targets

ACE (Angiotensin Converting Enzyme)SLC12A3 (Thiazide-sensitive sodium-chloride cotransporter)

Beyond the preview

Go deeper on fosinopril + hydrochlorothiazide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fosinopril + hydrochlorothiazide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call